167 related articles for article (PubMed ID: 7937153)
1. Functional differences between the Oct2 transactivation domains determine the transactivation potential of individual Oct2 isoforms.
Annweiler A; Zwilling S; Wirth T
Nucleic Acids Res; 1994 Oct; 22(20):4250-8. PubMed ID: 7937153
[TBL] [Abstract][Full Text] [Related]
2. Oct2 transactivation from a remote enhancer position requires a B-cell-restricted activity.
Annweiler A; Müller-Immerglück M; Wirth T
Mol Cell Biol; 1992 Jul; 12(7):3107-16. PubMed ID: 1620119
[TBL] [Abstract][Full Text] [Related]
3. Basal components of the transcription apparatus (RNA polymerase II, TATA-binding protein) contain activation domains: is the repetitive C-terminal domain (CTD) of RNA polymerase II a "portable enhancer domain"?
Seipel K; Georgiev O; Gerber HP; Schaffner W
Mol Reprod Dev; 1994 Oct; 39(2):215-25. PubMed ID: 7826625
[TBL] [Abstract][Full Text] [Related]
4. The retinoic acid receptor-beta 2 contains two separate cell-specific transactivation domains, at the N-terminus and in the ligand-binding domain.
Folkers GE; van der Leede BJ; van der Saag PT
Mol Endocrinol; 1993 Apr; 7(4):616-27. PubMed ID: 8389001
[TBL] [Abstract][Full Text] [Related]
5. The POU domains of the Oct1 and Oct2 transcription factors mediate specific interaction with TBP.
Zwilling S; Annweiler A; Wirth T
Nucleic Acids Res; 1994 May; 22(9):1655-62. PubMed ID: 8202368
[TBL] [Abstract][Full Text] [Related]
6. Domain structure of the NRIF3 family of coregulators suggests potential dual roles in transcriptional regulation.
Li D; Wang F; Samuels HH
Mol Cell Biol; 2001 Dec; 21(24):8371-84. PubMed ID: 11713274
[TBL] [Abstract][Full Text] [Related]
7. The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB.
Agostini I; Navarro JM; Rey F; Bouhamdan M; Spire B; Vigne R; Sire J
J Mol Biol; 1996 Sep; 261(5):599-606. PubMed ID: 8800208
[TBL] [Abstract][Full Text] [Related]
8. Functional domains of the heavy metal-responsive transcription regulator MTF-1.
Radtke F; Georgiev O; Müller HP; Brugnera E; Schaffner W
Nucleic Acids Res; 1995 Jun; 23(12):2277-86. PubMed ID: 7610056
[TBL] [Abstract][Full Text] [Related]
9. DNA-dependent transregulation by IE1 of Autographa californica nuclear polyhedrosis virus: IE1 domains required for transactivation and DNA binding.
Rodems SM; Pullen SS; Friesen PD
J Virol; 1997 Dec; 71(12):9270-7. PubMed ID: 9371585
[TBL] [Abstract][Full Text] [Related]
10. Differential transactivation potential of Oct1 and Oct2 is determined by additional B cell-specific activities.
Pfisterer P; Annweiler A; Ullmer C; Corcoran LM; Wirth T
EMBO J; 1994 Apr; 13(7):1654-63. PubMed ID: 8157005
[TBL] [Abstract][Full Text] [Related]
11. A unique transactivation sequence motif is found in the carboxyl-terminal domain of the single-strand-binding protein FBP.
Duncan R; Collins I; Tomonaga T; Zhang T; Levens D
Mol Cell Biol; 1996 May; 16(5):2274-82. PubMed ID: 8628294
[TBL] [Abstract][Full Text] [Related]
12. Functional comparison of the Mus musculus molossinus and Mus musculus domesticus Sry genes.
Dubin RA; Coward P; Lau YF; Ostrer H
Mol Endocrinol; 1995 Dec; 9(12):1645-54. PubMed ID: 8614401
[TBL] [Abstract][Full Text] [Related]
13. Functional differences between mammalian transcription activation domains at the yeast GAL1 promoter.
Künzler M; Braus GH; Georgiev O; Seipel K; Schaffner W
EMBO J; 1994 Feb; 13(3):641-5. PubMed ID: 8313909
[TBL] [Abstract][Full Text] [Related]
14. Requirements for utilization of CREB binding protein by hypersensitive site two of the beta-globin locus control region.
Johnson KD; Norton JE; Bresnick EH
Nucleic Acids Res; 2002 Apr; 30(7):1522-30. PubMed ID: 11917012
[TBL] [Abstract][Full Text] [Related]
15. C-terminal domain (CTD) of RNA-polymerase II and N-terminal segment of the human TATA binding protein (TBP) can mediate remote and proximal transcriptional activation, respectively.
Seipel K; Georgiev O; Gerber HP; Schaffner W
Nucleic Acids Res; 1993 Dec; 21(24):5609-15. PubMed ID: 8284205
[TBL] [Abstract][Full Text] [Related]
16. Oct2 transcription factor of a teleost fish: activation domains and function from an enhancer.
Cioffi CC; Pollenz RS; Middleton DL; Wilson MR; Miller NW; William Clem L; Warr GW; Ross DA
Arch Biochem Biophys; 2002 Aug; 404(1):55-61. PubMed ID: 12127069
[TBL] [Abstract][Full Text] [Related]
17. Three classes of mammalian transcription activation domain stimulate transcription in Schizosaccharomyces pombe.
Remacle JE; Albrecht G; Brys R; Braus GH; Huylebroeck D
EMBO J; 1997 Sep; 16(18):5722-9. PubMed ID: 9312030
[TBL] [Abstract][Full Text] [Related]
18. C-terminal activating and inhibitory domains determine the transactivation potential of BSAP (Pax-5), Pax-2 and Pax-8.
Dörfler P; Busslinger M
EMBO J; 1996 Apr; 15(8):1971-82. PubMed ID: 8617244
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional activation domain of the muscle-specific gene-regulatory protein myf5.
Braun T; Winter B; Bober E; Arnold HH
Nature; 1990 Aug; 346(6285):663-5. PubMed ID: 2385294
[TBL] [Abstract][Full Text] [Related]
20. Transcription factor Oct-2A contains functionally redundant activating domains and works selectively from a promoter but not from a remote enhancer position in non-lymphoid (HeLa) cells.
Müller-Immerglück MM; Schaffner W; Matthias P
EMBO J; 1990 May; 9(5):1625-34. PubMed ID: 2328728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
